Integral Health Asset Management’s Agilon Health AGL Stock Holding History

Integral Health Asset Management’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,000	Closed	-$4.08M	–	82
2023 Q4	$4.08M	Buy	+13,000	New	+$4.7M	0.56%	59
2022 Q3	–	Sell	-9,226	Closed	-$5.04M	–	66
2022 Q2	$5.04M	Buy	9,226 +2,226	+32%	+$1.13M	1.04%	34
2022 Q1	$4.44M	Buy	7,000 +2,000	+40%	+$1.03M	1.15%	33
2021 Q4	$3.38M	Sell	5,000 -2,200	-31%	-$1.34M	0.93%	35
2021 Q3	$4.72M	Buy	7,200 +3,200	+80%	+$2.73M	1.36%	28
2021 Q2	$4.06M	Buy	+4,000	New	+$3.5M	1.12%	36

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Integral Health Asset Management's AGL Position: Q1 2024 in Review

Integral Health Asset Management sold out of Agilon Health (AGL) in Q1 2024, closing a stake of 13,000 shares — an estimated $4.08M sold.

Integral Health Asset Management first reported a position in AGL in Q2 2021 and held it in 6 quarters. The position peaked at $5.04M in Q2 2022. 198 funds tracked by Wall St. Rank hold AGL as of Q1 2024.

Integral Health Asset Management reported no remaining Agilon Health position as of Q1 2024 after selling out during the quarter.
Integral Health Asset Management sold 13,000 Agilon Health shares in Q1 2024, an estimated $4.08M.
Integral Health Asset Management first reported a position in Agilon Health in Q2 2021 and held it in 6 quarters.
Integral Health Asset Management's Agilon Health position peaked at $5.04M in Q2 2022.
198 funds tracked by Wall St. Rank held Agilon Health as of Q1 2024.

Based on Integral Health Asset Management's 13F filing for Q1 2024, filed 15 May 2024.